Episode 89: Potential of CNM-Au8 Gold Nanocrystals to Treat ALS

James Berry, MD, PhD

Episode 89 of the NeurologyLive^® Mind Moments^® podcast is now live! Scroll down to listen or click here to subscribe on your favorite streaming service.

The Mind Moments podcast features exclusive interviews with leaders in the field discussing the latest research and disease management strategies across the breadth of neurology, including epilepsy, multiple sclerosis, Parkinson disease, dementia, sleep disorders, and more.

Episode 89, "Potential of CNM-Au8 to Treat ALS," features an exclusive interview with James Berry, MD, PhD, director of the Massachusetts General Hospital ALS Care Center. At the 2023 American Academy of Neurology Annual Meeting, he spoke about new data from a study assessing CNM-Au8, a nanocrystal formulation in development for patients with ALS. Additionally, he talked about the current unmet needs in the ALS community, including the need for more diverse treatment options and increased research.

This episode is brought to you by Medical World News, a streaming channel from MJH Life Sciences^®. Check out new content and shows every day, only at medicalworldnews.com

The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here:

• FDA Approves Brexpiprazole as First Therapy for Alzheimer Agitation
• FDA Panel Votes in Favor of Gene Therapy SRP-9001 for Duchenne Muscular Dystrophy in Tight Decision
• Alzheimer Agent COYA 301 Halts Cognitive Decline, Restores Regulatory T Cell Dysfunction in Phase 1 Study
• Phase 2 Data Highlight Fenebrutinib's Impact on Brain Lesions in Relapsing Multiple Sclerosis
  

EPISODE BREAKDOWN

• 1:15 – Clinical development program of CNM-Au8
• 3:40 – Safety findings, treatment responses of CNM-Au8
• 4:20 – Next steps in research 
• 6:25 – Neurology News Minute
• 8:45 – Conducting safe trials 
• 10:00 – Remaining unmet needs for patients with ALS
• 11:15 – Need for additional research

Click here to subscribe to the Mind Moments podcast. Be sure to leave a rating and review for the show. Thanks for listening!

Hoping to listen on your favorite podcast app? See below:

• Click here for Apple Podcasts
• Click here for Spotify
• Click here for Google Podcasts

REFERENCES
1. Berry J, Maragakis N, Paganoni S, et al. Evidence for Survival Benefit in ALS with CNM-Au8 Treatment Across Three Study Populations. Presented at: 2023 AAN Annual Meeting; April 22-27, Boston, Massachusetts.